Excise mandible lesion
CPT code 21040 is used when a surgeon removes a lesion (abnormal growth or tissue) from the mandible, which is your lower jawbone. This is a surgical procedure that involves cutting into the jaw to remove the problematic tissue.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify facility versus non-facility status before submitting claim to capture the $95.75 payment differential
Impact: Incorrect place of service coding results in automatic $95.75 underpayment (21% reduction) that often goes unnoticed and cannot be retroactively corrected after timely filing deadlines
Document lesion size, exact location on mandible (body, angle, ramus, symphysis), and depth of excision with photographic or radiographic evidence
Impact: Detailed documentation supports medical necessity and prevents denials; also justifies modifier 22 for complex cases which can increase payment by $90-$225
Bill bone grafting or complex reconstruction separately using appropriate CPT codes (21210, 21215) when performed, as these are not included in 21040
Impact: Failing to separately code grafting procedures results in undercharging by $400-$800 per case; ensure modifier 51 is properly applied
Verify pathology report is available before final claim submission to confirm lesion diagnosis matches pre-operative indication
Impact: Discrepancies between pre-op diagnosis and pathology can trigger medical necessity denials requiring time-consuming appeals; matching documentation reduces denial rate by approximately 15%
For Medicare patients, confirm that the lesion meets criteria for surgical excision rather than observation, as payer may deny if conservative management was not attempted
Impact: Lack of documentation showing progression, symptoms, or malignancy risk results in 20-30% denial rate on first submission
When performed in ASC setting, ensure facility also bills with appropriate ASC payment indicator to maximize total reimbursement
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.